216 related articles for article (PubMed ID: 32108268)
1. Epidemiology of hip fractures in Bulgaria: development of a country-specific FRAX model.
Kirilova E; Johansson H; Kirilov N; Vladeva S; Petranova T; Kolarov Z; Liu E; Lorentzon M; Vandenput L; Harvey NC; McCloskey E; Kanis JA
Arch Osteoporos; 2020 Feb; 15(1):28. PubMed ID: 32108268
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of osteoporotic fracture in Kazakhstan and development of a country specific FRAX model.
Issayeva S; Lesnyak O; Zakroyeva A; Issayeva B; Dilmanova D; Johansson H; Liu E; Lorentzon M; Harvey NC; McCloskey E; Kanis JA
Arch Osteoporos; 2020 Feb; 15(1):30. PubMed ID: 32108270
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of osteoporotic fracture in Moldova and development of a country-specific FRAX model.
Zakroyeva A; Lesnyak O; Cazac V; Groppa L; Russu E; Chislari L; Rotaru L; Johansson H; Harvey NC; McCloskey E; Lorentzon M; Kanis JA
Arch Osteoporos; 2020 Jan; 15(1):13. PubMed ID: 31993755
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of hip fracture in Belarus: development of a country-specific FRAX model and its comparison to neighboring country models.
Ramanau H; Chernyanin I; Rudenka E; Lesnyak O; Zakroyeva A; Bilezikian JP; Johansson H; Harvey NC; McCloskey EV; Kanis JA
Arch Osteoporos; 2018 Apr; 13(1):42. PubMed ID: 29666948
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of fractures in Armenia: development of a country-specific FRAX model and comparison to its surrogate.
Lesnyak O; Sahakyan S; Zakroyeva A; Bilezikian JP; Hutchings N; Babalyan V; Galstyan R; Lebedev A; Johansson H; Harvey NC; McCloskey E; Kanis JA
Arch Osteoporos; 2017 Nov; 12(1):98. PubMed ID: 29116417
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of hip fracture and the development of a FRAX model for Uzbekistan.
Lesnyak O; Ismailov S; Shakirova M; Alikhanova N; Zakroyeva A; Abboskhujaeva L; Johansson H; Harvey NC; McCloskey E; Kanis JA
Arch Osteoporos; 2020 Jul; 15(1):119. PubMed ID: 32728952
[TBL] [Abstract][Full Text] [Related]
7. Incidence of hip fracture in Saudi Arabia and the development of a FRAX model.
Saleh YAL; Sulimani RA; Alomary S; Alnajjar YI; Vandenput L; Liu E; Lorentzon M; Harvey NC; McCloskey EV; Johansson H; Kanis JA;
Arch Osteoporos; 2022 Apr; 17(1):56. PubMed ID: 35366737
[TBL] [Abstract][Full Text] [Related]
8. Incidence of hip fracture in Romania and the development of a Romanian FRAX model.
Grigorie D; Sucaliuc A; Johansson H; Kanis JA; McCloskey E
Calcif Tissue Int; 2013 May; 92(5):429-36. PubMed ID: 23334302
[TBL] [Abstract][Full Text] [Related]
9. Calibration of FRAX ® 3.1 to the Dutch population with data on the epidemiology of hip fractures.
Lalmohamed A; Welsing PM; Lems WF; Jacobs JW; Kanis JA; Johansson H; De Boer A; De Vries F
Osteoporos Int; 2012 Mar; 23(3):861-9. PubMed ID: 22120910
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of hip fracture and the development of FRAX in Ukraine.
Povoroznyuk VV; Grygorieva NV; Kanis JA; Ev M; Johansson H; Harvey NC; Korzh MO; Strafun SS; Vaida VM; Klymovytsky FV; Vlasenko RO; Forosenko VS
Arch Osteoporos; 2017 Dec; 12(1):53. PubMed ID: 28567714
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of hip fracture in Qatar and development of a country specific FRAX model.
Abdulla N; Alsaed OS; Lutf A; Alam F; Abdulmomen I; Al Emadi S; Harvey NC; Liu E; Vandenput L; Lorentzon M; McCloskey E; Kanis JA; Johansson H
Arch Osteoporos; 2022 Mar; 17(1):49. PubMed ID: 35303174
[TBL] [Abstract][Full Text] [Related]
12. Incidence of hip fracture in Brazil and the development of a FRAX model.
Zerbini CA; Szejnfeld VL; Abergaria BH; McCloskey EV; Johansson H; Kanis JA
Arch Osteoporos; 2015; 10():224. PubMed ID: 26303038
[TBL] [Abstract][Full Text] [Related]
13. Assessing the risk of osteoporotic fractures: the Ecuadorian FRAX model.
Lopez Gavilanez E; Johansson H; McCloskey E; Harvey NC; Segale Bajana A; Marriott Blum D; Navarro Grijalva M; Diaz Curiel M; Kanis JA
Arch Osteoporos; 2019 Aug; 14(1):93. PubMed ID: 31440846
[TBL] [Abstract][Full Text] [Related]
14. FRAX for fracture prediction shorter and longer than 10 years: the Manitoba BMD registry.
Leslie WD; Majumdar SR; Morin SN; Lix LM; Johansson H; Oden A; McCloskey EV; Kanis JA
Osteoporos Int; 2017 Sep; 28(9):2557-2564. PubMed ID: 28593449
[TBL] [Abstract][Full Text] [Related]
15. Updated fracture incidence rates for the Italian version of FRAX®.
Piscitelli P; Chitano G; Johannson H; Brandi ML; Kanis JA; Black DM
Osteoporos Int; 2013 Mar; 24(3):859-66. PubMed ID: 22638710
[TBL] [Abstract][Full Text] [Related]
16. A FRAX model for the estimation of osteoporotic fracture probability in Portugal.
Marques A; Mota A; Canhão H; Romeu JC; Machado P; Ruano A; Barbosa AP; Dias AA; Silva D; Araújo D; Simões E; Aguas F; Rosendo I; Silva I; Crespo J; Alves JD; Costa L; Mascarenhas M; Lourenço Ó; Ferreira PL; Lucas R; Roque R; Branco JC; Tavares V; Johansson H; Kanis J; Pereira da Silva JA
Acta Reumatol Port; 2013; 38(2):104-12. PubMed ID: 24141347
[TBL] [Abstract][Full Text] [Related]
17. Validation of FRAX and the impact of self-reported falls among elderly in a general population: the HUNT study, Norway.
Hoff M; Meyer HE; Skurtveit S; Langhammer A; Søgaard AJ; Syversen U; Dhainaut A; Skovlund E; Abrahamsen B; Schei B
Osteoporos Int; 2017 Oct; 28(10):2935-2944. PubMed ID: 28668994
[TBL] [Abstract][Full Text] [Related]
18. A surrogate FRAX model for the Kyrgyz Republic.
Lesnyak O; Zakroyeva A; Lobanchenko O; Johansson H; Liu E; Lorentzon M; Harvey NC; McCloskey E; Kanis JA
Arch Osteoporos; 2020 May; 15(1):68. PubMed ID: 32377964
[TBL] [Abstract][Full Text] [Related]
19. Development and application of FRAX in the management of osteoporosis in Ireland.
McGowan B; Kanis JA; Johansson H; Silke C; Whelan B
Arch Osteoporos; 2013; 8():146. PubMed ID: 23982943
[TBL] [Abstract][Full Text] [Related]
20. External validation and comparison of three prediction tools for risk of osteoporotic fractures using data from population based electronic health records: retrospective cohort study.
Dagan N; Cohen-Stavi C; Leventer-Roberts M; Balicer RD
BMJ; 2017 Jan; 356():i6755. PubMed ID: 28104610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
